Site directed mutagenesis of amino acid residues at the active site of mouse aldehyde oxidase AOX1. 2009

Silvia Schumann, and Mineko Terao, and Enrico Garattini, and Miguel Saggu, and Friedhelm Lendzian, and Peter Hildebrandt, and Silke Leimkühler
Universität Potsdam, Institut für Biochemie and Biologie, Potsdam, Germany.

Mouse aldehyde oxidase (mAOX1) forms a homodimer and belongs to the xanthine oxidase family of molybdoenzymes which are characterized by an essential equatorial sulfur ligand coordinated to the molybdenum atom. In general, mammalian AOs are characterized by broad substrate specificity and an yet obscure physiological function. To define the physiological substrates and the enzymatic characteristics of mAOX1, we established a system for the heterologous expression of the enzyme in Escherichia coli. The recombinant protein showed spectral features and a range of substrate specificity similar to the native protein purified from mouse liver. The EPR data of recombinant mAOX1 were similar to those of AO from rabbit liver, but differed from the homologous xanthine oxidoreductase enzymes. Site-directed mutagenesis of amino acids Val806, Met884 and Glu1265 at the active site resulted in a drastic decrease in the oxidation of aldehydes with no increase in the oxidation of purine substrates. The double mutant V806E/M884R and the single mutant E1265Q were catalytically inactive enzymes regardless of the aldehyde or purine substrates tested. Our results show that only Glu1265 is essential for the catalytic activity by initiating the base-catalyzed mechanism of substrate oxidation. In addition, it is concluded that the substrate specificity of molybdo-flavoenzymes is more complex and not only defined by the three characterized amino acids in the active site.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002942 Circular Dichroism A change from planar to elliptic polarization when an initially plane-polarized light wave traverses an optically active medium. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Circular Dichroism, Vibrational,Dichroism, Circular,Vibrational Circular Dichroism
D004578 Electron Spin Resonance Spectroscopy A technique applicable to the wide variety of substances which exhibit paramagnetism because of the magnetic moments of unpaired electrons. The spectra are useful for detection and identification, for determination of electron structure, for study of interactions between molecules, and for measurement of nuclear spins and moments. (From McGraw-Hill Encyclopedia of Science and Technology, 7th edition) Electron nuclear double resonance (ENDOR) spectroscopy is a variant of the technique which can give enhanced resolution. Electron spin resonance analysis can now be used in vivo, including imaging applications such as MAGNETIC RESONANCE IMAGING. ENDOR,Electron Nuclear Double Resonance,Electron Paramagnetic Resonance,Paramagnetic Resonance,Electron Spin Resonance,Paramagnetic Resonance, Electron,Resonance, Electron Paramagnetic,Resonance, Electron Spin,Resonance, Paramagnetic
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities

Related Publications

Silvia Schumann, and Mineko Terao, and Enrico Garattini, and Miguel Saggu, and Friedhelm Lendzian, and Peter Hildebrandt, and Silke Leimkühler
August 2002, Journal of protein chemistry,
Silvia Schumann, and Mineko Terao, and Enrico Garattini, and Miguel Saggu, and Friedhelm Lendzian, and Peter Hildebrandt, and Silke Leimkühler
January 1991, Advances in experimental medicine and biology,
Silvia Schumann, and Mineko Terao, and Enrico Garattini, and Miguel Saggu, and Friedhelm Lendzian, and Peter Hildebrandt, and Silke Leimkühler
November 2006, The FEBS journal,
Silvia Schumann, and Mineko Terao, and Enrico Garattini, and Miguel Saggu, and Friedhelm Lendzian, and Peter Hildebrandt, and Silke Leimkühler
January 1989, Biochemistry,
Silvia Schumann, and Mineko Terao, and Enrico Garattini, and Miguel Saggu, and Friedhelm Lendzian, and Peter Hildebrandt, and Silke Leimkühler
March 2005, Biochemistry,
Silvia Schumann, and Mineko Terao, and Enrico Garattini, and Miguel Saggu, and Friedhelm Lendzian, and Peter Hildebrandt, and Silke Leimkühler
March 1990, The Journal of biological chemistry,
Silvia Schumann, and Mineko Terao, and Enrico Garattini, and Miguel Saggu, and Friedhelm Lendzian, and Peter Hildebrandt, and Silke Leimkühler
October 2002, European journal of biochemistry,
Silvia Schumann, and Mineko Terao, and Enrico Garattini, and Miguel Saggu, and Friedhelm Lendzian, and Peter Hildebrandt, and Silke Leimkühler
August 2000, The Journal of biological chemistry,
Silvia Schumann, and Mineko Terao, and Enrico Garattini, and Miguel Saggu, and Friedhelm Lendzian, and Peter Hildebrandt, and Silke Leimkühler
September 2005, Biochimica et biophysica acta,
Silvia Schumann, and Mineko Terao, and Enrico Garattini, and Miguel Saggu, and Friedhelm Lendzian, and Peter Hildebrandt, and Silke Leimkühler
April 1997, Journal of protein chemistry,
Copied contents to your clipboard!